Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Cancer Drug Targets|November 10, 2015
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in OsteosarcomaMarilù Fanelli, Claudia Maria Hattinger, Serena Vella, et al.
Annals of the New York Academy of Sciences|March 8, 2007
Induction of apoptosis of osteoclasts by targeting transcription factors with decoy moleculesRoberta Piva, Letizia Penolazzi, Margherita Zennaro, et al.
Frontiers in Oncology|March 27, 2020
Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored TreatmentsMarilù Fanelli, Elisa Tavanti, Maria Pia Patrizio, et al.
Antioxidants (Basel, Switzerland)|August 9, 2019
Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and InflammationVeronica Tisato, Arianna Romani, Elisa Tavanti, et al.
Tissue Engineering. Part C, Methods|May 1, 2009
Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate microbeadsLetizia Penolazzi, Elisa Tavanti, Renata Vecchiatini, et al.
Investigational New Drugs|September 7, 2014
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistanceValeria Sero, Elisa Tavanti, Serena Vella, et al.
Cellular and Molecular Life Sciences : CMLS|November 16, 2018
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcomaIlaria Buondonno, Elena Gazzano, Elisa Tavanti, et al.
Oncotarget|August 28, 2016
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcomaClaudia M Hattinger, Paola Biason, Erika Iacoboni, et al.
Pageof 2